Zacks Research Forecasts Weaker Earnings for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Equities researchers at Zacks Research cut their Q1 2025 EPS estimates for shares of Teladoc Health in a research note issued to investors on Wednesday, March 12th. Zacks Research analyst R. Department now forecasts that the health services provider will earn ($0.40) per share for the quarter, down from their previous forecast of ($0.38). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health’s Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($1.08) EPS, Q2 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.90) EPS.

TDOC has been the subject of several other research reports. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Bank of America boosted their price objective on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Royal Bank of Canada raised their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $11.26.

Teladoc Health Trading Up 2.8 %

NYSE:TDOC opened at $8.86 on Monday. Teladoc Health has a one year low of $6.76 and a one year high of $15.68. The business has a fifty day moving average price of $10.54 and a 200-day moving average price of $9.73. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.54 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.

Institutional Trading of Teladoc Health

Large investors have recently added to or reduced their stakes in the company. Point72 Asset Management L.P. increased its holdings in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after buying an additional 3,063,172 shares during the last quarter. Maple Rock Capital Partners Inc. increased its stake in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP bought a new stake in Teladoc Health during the fourth quarter worth approximately $18,348,000. Two Sigma Advisers LP raised its position in Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of Teladoc Health by 5.9% in the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.